| 注册
首页|期刊导航|检验医学与临床|甲状腺癌患者BRAF V600E基因突变与民族及临床病理特征的关系

甲状腺癌患者BRAF V600E基因突变与民族及临床病理特征的关系

刘超宇 黄林达 马燕飞 潘秀虹 朱晓莹

检验医学与临床2024,Vol.21Issue(9):1235-1240,6.
检验医学与临床2024,Vol.21Issue(9):1235-1240,6.DOI:10.3969/j.issn.1672-9455.2024.09.010

甲状腺癌患者BRAF V600E基因突变与民族及临床病理特征的关系

Relationship of BRAF V600E gene mutation and nationality and clinicopathological characteristics in thyroid cancer

刘超宇 1黄林达 1马燕飞 2潘秀虹 3朱晓莹1

作者信息

  • 1. 右江民族医学院附属医院临床病理诊断与研究中心,广西百色 533000||广西肝胆疾病分子病理学重点实验室,广西百色 533000||广西高校肿瘤分子病理学重点实验室,广西百色 533000
  • 2. 右江民族医学院附属医院腺体外科,广西百色 533000
  • 3. 右江民族医学院附属医院血液内科,广西百色 533000
  • 折叠

摘要

Abstract

Objective To explore the relationship between BRAF V600 E gene mutations and nationality and clinicopathologic characteristics of thyroid cancer patients.Methods Three hundred patients with thyroid cancer diagnosed at the Affiliated Hospital of Youjiang Medical College for Nationalities from January 2021 to January 2023 were selected and divided into 150 cases of the Zhuang nationality and 150 cases of Han national-ity according to the patients'nationality,and their pathologic specimens were collected.Real-time fluorescence quantitative polymerase chain reaction(qRT-PCR)was used to detect gene mutations at the V600 E locus of the BRAF gene.Results Among the 300 thyroid cancer patients,221 cases were mutated and 79 cases were wild-type.The difference of the gene mutation rate at the V600 E locus of the BRAF gene of patients with thy-roid cancer in the Zhuang nationality and the Han nationality(72.00%vs.75.33%)showed no statistical sig-nificance(P>0.05).The difference of mutation rates at the V600 E locus of the BRAF gene between different genders of the same nationality showed statistical significance(P<0.01);the difference of mutation rates at the V600 E locus of the BRAF gene between different nationalities of the same gender showed statistical signif-icance(P<0.01).The mutation rate of BRAF gene at the V600 E locus in thyroid cancer patients<40 years old was 88.67%,which was significantly higher than that of 58.67%in patients≥40 years old,and the differ-ence was statistically significant(P<0.05);however,the differences of the mutation rates of BRAF gene at the V600 E locus in thyroid cancer patients with different maximum tumor diameters and different numbers of lymph nodes were not statistically significant(P>0.05).There was no statistically significant difference in mutation rates at the V600 E locus of the BRAF gene among patients with different nationalities within the same age range(P>0.05).The difference of mutation rates at the V600 E locus of the BRAF gene between thyroid patients of different nationalities with a maximum tumor diameter of<2 cm had statistically signifi-cant difference(P>0.05),but the difference of mutation rates at the V600 E locus of the BRAF gene between thyroid patients of different nationalities with maximum tumor diameters of 2-4 cm was statistically signifi-cant difference(P=0.001).The difference of mutation rates at the V600 E locus of the BRAF gene among thyroid patients of different nationalities with the same number of lymph nodes showed no statistical signifi-cance(P>0.05).The difference of the mutation rate at the V600 E locus of BRAF gene in papillary thyroid cancer patients with different nationalities was statistically significant(P<0.05),but the differences of muta-tion rate at the V600 E locus of BRAF gene in patients with follicular thyroid cancer and undifferentiated thy-roid cancer in patients with different nationalities were not statistically significant(P>0.05).Conclusion The gene mutation rate at the V600 E locus of the BRAF gene in thyroid cancer patients in Baise City is related to na-tionality,gender,maximum diameter of the tumor and tumor type.

关键词

甲状腺癌/BRAF V600E基因突变/壮族/汉族/临床病理特征

Key words

thyroid cancer/BRAF V600 E gene mutation/Zhuang nationality/Han nationality/clinicopathological features

分类

医药卫生

引用本文复制引用

刘超宇,黄林达,马燕飞,潘秀虹,朱晓莹..甲状腺癌患者BRAF V600E基因突变与民族及临床病理特征的关系[J].检验医学与临床,2024,21(9):1235-1240,6.

基金项目

2019年度百色市科学研究与技术开放计划项目[百科字(2019)31号-30] (2019)

广西临床重点专科(病理)建设项目(桂卫医发[2022]21号). (病理)

检验医学与临床

OACSTPCD

1672-9455

访问量0
|
下载量0
段落导航相关论文